Profile data is unavailable for this security.
About the company
Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of in vitro diagnostic rapid diagnostic products. The Company's main products include whole blood respiratory tract marker 5-item test kits, influenza antigen 3-item test kits, influenza antibody 3-item test kits, serum respiratory tract marker 5-item test kits, respiratory fluorescence 9-item test kits and others. These products are mainly used for the detection of respiratory pathogens, gastrointestinal pathogens, hepatitis diagnostics and others. The Company mainly conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)430.96m
- Net income in CNY133.44m
- Incorporated2006
- Employees547.00
- LocationInnovita Biological Technology Co Ltd1F, 2F, Block 6, No. 1Haiying Road, Fengtai DistrictBEIJING 100070ChinaCHN
- Phone+86 1 083682249
- Fax+86 1 083682966
- Websitehttps://www.innovita.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jianerkang Medical Co Ltd | 988.21m | 103.17m | 4.44bn | 1.64k | 17.85 | 3.04 | -- | 4.49 | 1.59 | 1.59 | 8.03 | 9.35 | 0.6961 | 4.54 | 4.50 | 603,301.80 | 7.27 | -- | 8.08 | -- | 23.15 | -- | 10.44 | -- | 7.07 | -- | 0.0146 | -- | 1.18 | -- | -2.69 | -- | -- | -- |
| Nanjing Medlander Medical Tech Co Ltd | 437.82m | 101.51m | 4.46bn | 582.00 | 42.98 | 3.26 | -- | 10.19 | 1.04 | 1.04 | 4.47 | 13.68 | 0.2865 | 2.18 | 15.40 | 752,267.60 | 6.81 | 11.96 | 7.54 | 13.89 | 69.16 | 71.98 | 23.76 | 31.41 | 8.22 | -- | 0.0268 | 48.42 | 24.57 | 10.68 | 13.10 | -0.8601 | 23.21 | -- |
| Getein Biotech Inc | 1.04bn | 181.90m | 4.51bn | 1.95k | 24.79 | 1.68 | -- | 4.32 | 0.3587 | 0.3587 | 2.06 | 5.31 | 0.2683 | 1.68 | 2.68 | 535,523.10 | 4.41 | 10.90 | 6.31 | 15.53 | 67.54 | 64.96 | 16.43 | 25.58 | 2.14 | -- | 0.1839 | 31.15 | -14.93 | 3.77 | -20.06 | -8.02 | 4.62 | -2.48 |
| Thalys Medical Technology Group Corp | 1.25bn | -240.46m | 4.67bn | 1.25k | -- | 4.28 | -- | 3.74 | -1.35 | -1.35 | 6.55 | 5.19 | 0.4777 | 3.80 | 1.12 | 1,001,425.00 | -9.15 | -2.70 | -16.94 | -4.93 | 18.26 | 20.43 | -19.16 | -4.59 | 1.16 | -2.08 | 0.357 | -- | -9.74 | -0.2204 | -31.95 | -- | -24.80 | -- |
| Chimin Health Management Co Ltd | 637.78m | -165.28m | 4.72bn | 1.99k | -- | 3.36 | -- | 7.39 | -0.3276 | -0.3276 | 1.24 | 2.67 | 0.2591 | 3.15 | 3.72 | 319,848.50 | -6.70 | 0.4271 | -9.09 | 0.6335 | 27.94 | 42.63 | -25.86 | 1.16 | 0.8238 | -8.24 | 0.3308 | 65.53 | -13.28 | 0.1151 | 8.81 | -- | -1.88 | -- |
| CareRay Digital Medical Technology CoLtd | 328.62m | 5.41m | 4.74bn | 282.00 | 825.27 | 5.52 | -- | 14.41 | 0.0651 | 0.0651 | 3.79 | 9.74 | 0.3392 | 1.69 | 3.66 | 1,165,314.00 | 0.5362 | 4.81 | 0.5972 | 5.27 | 36.13 | 40.00 | 1.58 | 12.87 | 3.57 | 1.77 | 0.0497 | 34.94 | 8.90 | 4.91 | 14.54 | -18.19 | 85.59 | -- |
| Innovita Biological Technology Co Ltd | 430.96m | 133.44m | 4.81bn | 547.00 | 35.94 | 2.37 | -- | 11.17 | 0.9778 | 0.9778 | 3.15 | 14.84 | 0.1992 | 2.28 | 12.73 | 787,869.50 | 6.17 | 18.66 | 6.52 | 20.97 | 76.43 | 78.34 | 30.96 | 43.42 | 16.16 | -- | 0.0025 | 12.05 | 29.99 | 35.11 | 41.92 | 63.25 | 28.63 | -- |
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.98bn | 744.00 | 18.19 | 2.00 | -- | 7.44 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
| Zhejiang Orient Gene Biotech Co Ltd | 842.11m | -479.50m | 5.01bn | 2.28k | -- | 0.787 | -- | 5.94 | -2.48 | -2.48 | 4.37 | 31.55 | 0.107 | 1.44 | 3.39 | 369,997.60 | -6.68 | 21.19 | -7.77 | 26.74 | 34.88 | 58.52 | -62.43 | 32.42 | 3.86 | -- | 0.0462 | 24.78 | 0.946 | 17.65 | -33.06 | -- | 138.80 | -- |
| Assure Tech (Hangzhou) Co Ltd | 462.72m | 120.87m | 5.04bn | 741.00 | 41.72 | 0.9768 | -- | 10.90 | 0.9511 | 0.9511 | 3.64 | 40.62 | 0.0809 | 2.22 | 2.17 | 624,449.30 | 2.11 | 23.69 | 2.30 | 28.01 | 30.32 | 64.61 | 26.11 | 47.65 | 11.28 | -- | 0.0012 | 18.78 | 7.42 | 20.85 | 35.85 | 28.69 | 63.16 | -- |
Data as of Feb 11 2026. Currency figures normalised to Innovita Biological Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 776.15k | 2.60% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2025 | 372.59k | 1.25% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 221.45k | 0.74% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 73.70k | 0.25% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 66.09k | 0.22% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 61.97k | 0.21% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 49.56k | 0.17% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 49.06k | 0.16% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 37.33k | 0.13% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 34.76k | 0.12% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
